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factor (rho). Genetic reconstruction experiments demonstrate that the sigA G336C substitution, in 24 the domain that recognizes the -35 promoter region, is sufficient to reduce susceptibility to VAN 25 and works cooperatively with the rho G56C substitution to increase CEF resistance. Transcriptome 26 analyses reveal that the sigA G336C substitution has wide-ranging effects including elevated 27 expression of the general stress σ factor (σ B ) regulon, which is required for CEF resistance, and 28 decreased expression of the glpTQ genes, which leads to fosfomycin (FOS) resistance. Our 29 findings suggest that mutations in the core transcriptional machinery may facilitate the evolution 30 of resistance to multiple cell wall antibiotics. 31
INTRODUCTION 33
The evolution of multidrug-resistance among pathogenic bacteria is an increasing threat to 34 global public health because the rate of resistance evolution far outpaces that of development of 35 new antibiotics (1-3). Combinations of antibiotics have emerged as a promising strategy to 36 enhance antibiotic effectiveness (4, 5), and they are commonly classified as additive (no 37 interaction), synergistic (greater than additive effect), or antagonistic (less than additive effect) (6, 38 7). The synergistic interactions between glycopeptides and β-lactams have been demonstrated 39 the disk diffusion assays: cefuroxime, 50 µg; ceftazidime, 30 µg; ceftriaxone, 30 µg; ampicillin, 132 50 µg; penicillin G, 50 µg; piperacillin, 100 µg; oxacillin, 1 µg; and fosfomycin, 100 µg or 500 133
µg. 134
Minimum inhibitory concentration assays. The Etest assay was performed similarly to the 135 disk diffusion assay. Etest strips (bioMérieux) impregnated with VAN or CEF (concentration 136 ranging from 0.016 to 256 μg/ml) were applied to MH agar plates, and the plates were incubated 137 at 37°C for 16-18 h. The MIC was determined from the scale at the intersection of bacterial 138 growth with the Etest strip. For the growth inhibition assay, strains were grown to an OD 600 of 139 0.4 and then diluted 1:400 in MH broth. Aliquots (200 µl) of the diluted cultures were dispensed 140 in a Bioscreen 100-well microtiter plate and a range of at least 9 antibiotic concentrations close 141 to the MIC were added to each well. Growth was measured spectrophotometrically (OD 600 ) 142 every 30 min for 24 h using a Bioscreen C microbial growth analyzer at 37°C with continuous 143
shaking. MIC was defined as the lowest concentration of antibiotic that completely inhibited 144 growth (OD 600 <0.2) at the 16 h or 24 h time point. 145 RNA preparation and microarray analyses. Total RNA was isolated from strains HB13679 146 (sigA WT -mls) and HB13680 (sigA G336C -mls) grown in LB medium to an OD 600 of 0.4, using the 147 RNeasy mini kit (Qiagen), followed by DNase treatment with TURBO DNA free (Ambion). The 148 quantity and purity of RNA was determined using a NanoDrop spectrophotometer. Two 149 microarrays were performed in biological triplicates with a dye swap. cDNA labeling and 150 microarray analysis were performed as described (44). The GenePix Pro software package 151 (version 6.0) was used for image processing and analysis. The normalized microarray data sets 152 were filtered to remove those genes that were not expressed at levels significantly above 153 background under either condition (sum of mean fluorescence intensities, <20). In addition, the 154 on August 15, 2017 by guest http://jb.asm.org/ Downloaded from mean and standard deviation of the fluorescence intensities were computed for each gene, and 155 those for which the standard deviation was greater than the mean value were ignored. The fold 156 change was calculated by using the average signal intensities for HB13680 divided by those for 157
HB13679. 158
RT-PCR assay. For reverse transcription-PCR (RT-PCR), total RNA (1 μg) was reverse 159 transcribed into cDNA by using random hexamers and a TaqMan reverse transcription kit 160 (Roche). The cDNA was then amplified by PCR using gene-specific primer sets (Table 1) . The 161 reaction mixture was denatured (95°C, 3 min), followed by 20 thermal cycles (95°C for 30 s, 162 54°C for 30 s, and 72°C for 1 min) and a final extension (72°C for 10 min). Primer pair 163 6094(glpT RT-F)/6095(glpT RT-R) was used to detect the glpT transcript. 16S rRNA was used as 164 a normalization control. PCR products were separated on a 1.5% agarose gel, stained with 165 ethidium bromide, and visualized. 166
Microarray data accession number. The microarray data set is available in the NCBI GEO 167 database under accession number GSE55202. 168
169

RESULTS AND DISCUSSION
170
Development of resistance to the combination of VAN and CEF in B. subtilis. We combined 171 experimental evolution and whole-genome sequencing to define a pathway enabling B. subtilis to 172 develop increased resistance to the combination of VAN and CEF. B. subtilis W168 has MICs in 173 MH medium of 0.25 µg/ml for vancomycin and 6 µg/ml for cefuroxime. When either antibiotic 174 was present at 0.5x MIC, the observed MIC for the other was reduced by ~2-fold, indicative of 175 synergism. To select for increased resistance against this combination of cell wall antibiotics, 176 on August 15, 2017 by guest http://jb.asm.org/ Downloaded from wild-type cells were continuously sub-cultured for 10 days with increasing concentrations of 177 both antibiotics. Cells were taken every day before sub-culturing for frozen bacterial stocks, and 178 their growth rates were measured spectrophotometrically using a Bioscreen C growth analyzer at 179 37 °C. As cells grew very slowly from day 7 (Fig. 1A) , we focused on the day 6 strain. We first 180 isolated a single colony of the evolved strain (HB13513) by streaking it onto an LB agar plate, 181 and determined the MICs for VAN and CEF by using Etest assay. Strain HB13513 displayed ~8-182 fold increased MIC for CEF, together with a modest (≤2-fold) increase in the MIC for VAN (Fig.  183   1B) . These data suggest that B. subtilis HB13513 has undergone significant evolution of CEF 184 resistance. Despite extended exposure to VAN, only a modest decrease in VAN susceptibility 185 was observed in this B. subtilis isolate. 186
Identification of mutations that drive evolution of reduced antibiotic susceptibility. To 187 identify the genomic basis of these changes in susceptibility to VAN and CEF, we used whole-188 genome resequencing of HB13513 and its parental wild-type to reveal four SNPs that distinguish 189 these two strains. These four SNPs affect three genes (sigA, mreB and rho) and lead to single 190 amino acid changes in each encoded protein. These mutations were confirmed by Sanger DNA 191 sequencing (Fig. 1C) . 192
When antibiotic susceptibility was evaluated by the growth inhibition assay or Etest 193 assay, MICs for VAN and CEF gradually increased over time as expected (Fig. 1D) . To 194 determine the order of fixation of these mutations we sequenced these loci in each sequential 195 daily culture. As shown in Fig. 1E , evolution proceeded through the sequential fixation of 196 mutations in the rho, sigA, and mreB genes. The first arising mutation (rho G56C ) correlates with 197 an ~4-fold increase in CEF resistance with another significant increase associated with the next 198 two mutations at days 4 and 5 (which were also correlated with an increase in the MIC for VAN) . 
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The sigA G336C substitution is responsible for both altered growth and reduced VAN 200 susceptibility. To determine which of these mutations confer the reduced susceptibility to VAN 201 and/or CEF, we moved each point mutation into the parental wild-type strain as described 202 previously (2). An antibiotic resistance cassette was introduced as a selectable marker either after 203 the stop codon or before the promoter region of each gene ( Fig. 2A) . These genetic 204 reconstruction experiments demonstrated that the altered growth phenotype (longer lag phase) 205 results from the sigA G336C substitution (Fig. 2B ). This is consistent with the appearance of this 206 mutation in the day 4 culture (Fig. 1E) , which also had a longer lag phase ( To identify genetic determinants that affect susceptibility to VAN, we compared the 211 growth rates of the reconstructed strains in the presence of VAN using a Bioscreen C growth 212 analyzer. As shown in Fig. 2C , the sigA G336C substitution is largely responsible for the reduced 213 VAN susceptibility, although the mreB L201S substitution also has a slight effect. These results 214 suggest that the sigA G336C substitution is sufficient for reduced VAN susceptibility (comparable to 215 that noted in strain HB13513; Fig. 2C ), but this change also results in overall reduced fitness (Fig.  216 
2B). 217
Although the sigA G336C substitution occurred at day 4 and the mreB L201S substitution 218 occurred at day 5 (Fig. 1E ), the cultures from days 2 and 3 were also slightly less susceptible to 219 VAN (Fig. 1D ). This may be due to induction of an adaptive tolerance response. For example, 220 VAN is known to be an inducer of several cell envelope stress responses including the σ The sigA G336C and rho G56C alleles together reduce susceptibility to CEF. A similar genetic 223 reconstruction strategy was used to identify the determinants of reduced CEF susceptibility in 224
HB13513. These studies demonstrate that both sigA G336C and rho G56C reduce CEF susceptibility, 225 and the combination is sufficient to confer a 9-fold increase in MIC (Fig. 3) . In contrast, the 226 mreB L201S substitution was not directly involved in CEF resistance (Fig. 3A) . Notably, the 227 rho G56C substitution led to an over 4-fold increase in the CEF MIC in the Etest assays (Fig. 3B) . 228
These results suggest that the reduced susceptibility to CEF in the HB13513 strain is attributable 229 to the effects of both sigA G336C and rho G56C . antagonistically with respect to β-lactams. Moreover, the rho null mutant displayed a reduced 246 sensitivity to other broad spectrum β-lactams, especially cephalosporins (Fig. 4D) . 247
In B. subtilis, global transcriptomics approaches have recently revealed that a rho null 248 mutant results in numerous extended mRNAs (up to 12 kb), thereby affecting the expression of 249 dozens of downstream genes that collectively comprise ~2% of the genome (55). Interestingly, 250
penP, which encodes a putative β-lactamase, is among the genes with 3' extended mRNAs in a 251 rho null mutant. We therefore hypothesized that a rho null mutation might affect levels or 252 translation of penP mRNA, possibly accounting for the observed CEF resistance. However, penP 253
is not required for β-lactam resistance in the rho null mutant (Fig. 4E) . 254
As β-lactams target the PBPs, we also examined the impact of pbp gene deletions on the 255 reduced CEF susceptibility in the rho null mutant. Previously, we used a Bocillin-FL competition 256 assay to demonstrate that CEF targets PBP1 (ponA), PBP2b (pbpB), PBP2c (pbpF), and PBP4 257 (pbpD) (56). To determine if increased expression of one or more of these PBPs might contribute 258 to elevated CEF resistance we measured resistance of rho null strains additionally lacking one or 259 more PBP in a zone of inhibition assay. However, none of the deletions tested led to a significant 260 change in CEF resistance in the rho null mutant. For example, rho null mutant strains 261 additionally carrying mutations in ponA, pbpD, pbpF, pbpG or dacA were at least as resistant to 262 CEF as the rho null mutant, and even a quadruple mutant (rho, pbpD, pbpF, pbpG) was as 263 resistant as the rho single mutant (data not shown). Thus, we conclude that inactivation of rho is 264 a new genetic mechanism affecting β-lactam susceptibility in B. subtilis, but our results do not 265 explain why this mutation confers resistance. 266
The sigA G336C substitution affects sensitivity to multiple antibiotics. We next sought to 267 determine how the sigA G336C mutation alters antibiotic susceptibility. The sigA G336C substitution is 268 on August 15, 2017 by guest http://jb.asm.org/ Downloaded from located in the helix-turn-helix motif in region 4 that recognizes the -35 promoter element (Fig.  269   5A ). Since sigA is essential, we hypothesized that this is an altered function mutation likely 270 affecting either core-binding, promoter recognition, or possibly interaction with one or more 271 regulatory proteins (57). We used disk diffusion assays to determine whether the sigA G336C 272 substitution affected susceptibility to other cell wall antibiotics including fosfomycin, bacitracin, 273 and D-cycloserine. Indeed, the sigA G336C substitution made B. subtilis highly resistant to FOS, 274 whereas the substitutions in mreB and rho did not (Fig. 5B ). Our results demonstrate that the 275 sigA G336C substitution alone leads to reductions in susceptibility for CEF, VAN, and FOS. 276
The sigA G336C substitution alters the transcriptome. We used microarray-based gene 277 expression profiling to better understand the genetic basis for resistance to antibiotics in the 278 sigA G336C mutant. This mutation clearly leads to genome-wide changes in gene expression 279 between the mutant (HB13680) and wild-type (HB13679) strains even under non-stress 280 conditions (Fig. 5C) . Significantly, in the sigA G336C mutant (HB13680) 28 genes of the σ B general 281 stress response regulon (58) were upregulated >2-fold, and other operons (including glpTQ) were 282 strongly (>4-fold) down-regulated (Fig. 5C) the sigB null mutant background. Indeed, the opposite was observed: the sigB sigA G336C double 293 mutant was more sensitive to CEF than the sigB single mutant as judged by the diameter of 294 growth inhibition (Fig. 6) . However, after overnight growth there was weak growth in the 295 sigA G336C mutant strain relatively close to the disk, consistent with some protective effect (Fig. 6,  296 upper right). Nevertheless, these results suggest that sigB is critical for the ability of the 297 sigA G336C mutation to increase CEF resistance, consistent with the elevated expression of the σ
regulon observed in the mutant strain (Fig. 5C ). There are ~200 genes in the σ B regulon (59-62), 299 and the identity of the gene(s) that mediate increased reduced susceptibility to CEF are yet 300
unknown. 301
The sigA G336C substitution mediates FOS resistance by decreased expression of glpTQ. We 302 next sought to define the mechanism by which the sigA G336C substitution confers resistance to 303 FOS, which unlike CEF and VAN acts on the very early, cytosolic steps of peptidoglycan 304 biogenesis. We have shown previously that the σ W -regulated fosB gene is a major FOS resistance 305 determinant (63), and a bshC-null mutant lacking bacillithiol (BSH), a cofactor for the FosB 306 bacillithiol transferase, is also highly FOS sensitive (64). Although cells lacking FosB or BshC 307 are very sensitive to FOS, they still displayed an increase in FOS resistance upon introduction of 308 the sigA G336C allele (Fig. 7A) . We conclude that the sigA G336C allele can act independently of 309 FosB. Motivated by our characterization of the transcriptional changes resulting from the 310 sigA G336C substitution (Fig. 5C ), we next asked whether σ B might be involved in FOS resistance. 311
In contrast with the results with CEF, disruption of sigB had no significant effect on the ability of 312 the sigA G336C substitution to confer FOS resistance (data not shown). 313
Mutations in glpT are known to be one mechanism for FOS resistance (65, 66) because 314 on August 15, 2017 by guest http://jb.asm.org/
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GlpT is a glycerol-3-phosphate permease via which FOS enters the cell (67). The observed 315 decrease in the transcription level of glpT seen in the microarray (Fig. 5C ) was confirmed by RT-316 PCR analysis (Fig. 7B) . This decreased expression is functionally significant since the sigA G336C 317 mutant displayed a growth defect in minimal medium containing 2% glycerol-3-P, suggesting 318 that it has lower levels of GlpT (Fig. 7C) . To test whether this decreased expression of glpTQ 319 was responsible for FOS resistance, the glpTQ operon was expressed under the control of the 320 IPTG-inducible P spac(hy) promoter after integration into the amyE locus of the sigA G336C mutant. 321
Indeed, IPTG induction of glpTQ restored FOS sensitivity (Fig. 7D) . These results suggest that 322 the sigA G336C substitution decreases the expression of glpTQ, and this decrease is sufficient to 323
confer FOS resistance. 324
The molecular basis for the decreased expression of the glpTQ operon in the sigA G336C 325 mutant is unclear. We noticed that the residue affected by this mutation (G336) is close to 326 residues previously implicated in contacting activator proteins. Specifically, amino acids near 327 and within the first helix of the HTH motif in region 4 of the E. coli σ 70 mediate contact with the 328 response regulator PhoB (68). Therefore, we speculated that SigA G336C may be defective for 329 interaction with PhoP (equivalent of the E. coli PhoB) or other similar regulators. However, 330 almost all PhoP-regulated genes are essentially unchanged in the sigA G336C mutant (Fig. 5C and  331 data not shown), suggesting that PhoPR activity is not affected by SigA G336C . It is also known 332 that only the glpQ gene of the glpTQ operon is under the control of PhoPR (69), and glpT has a 333 SigA-type promoter (70). Thus, it is likely that transcription of the glpTQ operon is reduced 334 directly due to a change in the promoter activation function of SigA G336C . 335
Conclusions. Our data highlight the ability of mutational changes in the core transcriptional 336 machinery to drive the evolution of decreased sensitivity to antibiotics in B. subtilis. Escherichia coli transcription termination factor Rho has a two-domain structure in its 485 
